CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank43
5Y CAGR-52.1%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
-52.1%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
0x
Contraction
Streak
4 yr
Consecutive growthAccelerating
PeriodValue
20251.93%
2024-2.33%
2023-15.28%
2022-193.87%
2021-295.79%
202076.93%
2019-185.15%
2018147.58%
2017493.21%
2016-95.23%